THIEL-BACKED DRUG-ENHANCED SPORTS EVENT GOES PUBLIC

Enhanced went public through a merger with a blank-check company, securing $1.2 billion in valuation. The venture represents a departure from traditional sports governance, explicitly allowing athletes to use performance-enhancing substances. Co-founder and CEO Maximilian Martin announced the listing on the New York Stock Exchange floor. The company's model directly challenges conventional Olympic and competitive sports standards that prohibit such substances. Thiel's investment signals continued interest in contrarian ventures. Srinivasan's involvement connects the initiative to the broader crypto and tech investment sphere. The first event occurs in Las Vegas this month, testing whether audiences and athletes will embrace the alternative competition format. The move raises questions about regulatory oversight, athlete safety, and the future of performance-enhancement policies in organized sports.